Successfully Acquiring a Biosimiliar in Drug Delivery for Partnering
Add bookmark
Pharma IQ interviews Christopher Slavinsky, Assistant General Council, Established Products Brand, Pfizer, Inc., who discusses how to successfully acquire a biosimiliar in drug delivery for partnering.
